Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat in female patients with functional constipation
NCT01038687Phase 2Completed
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of elobixibat in functional constipation (FC). Primary endpoint: Colonic Transit at 24 Hours. Started Jan 2010; status: completed.
02
Drugs
elobixibat
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT01038687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038687.